Citation tools
"The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action." Journal of Pharmacology and Experimental Therapeutics
373.1
(2020):
92-102.
Web. 20 April. 2024.